lactic acid has been researched along with Age-Related Macular Degeneration in 8 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lambert, V | 1 |
Hansen, S | 1 |
Schoumacher, M | 1 |
Lecomte, J | 1 |
Leenders, J | 1 |
Hubert, P | 1 |
Herfs, M | 1 |
Blacher, S | 1 |
Carnet, O | 1 |
Yip, C | 1 |
Blaise, P | 1 |
Duchateau, E | 1 |
Locht, B | 1 |
Thys, M | 1 |
Cavalier, E | 1 |
Gothot, A | 1 |
Govaerts, B | 1 |
Rakic, JM | 1 |
Noel, A | 1 |
de Tullio, P | 1 |
Klipfel, L | 1 |
Cordonnier, M | 1 |
Thiébault, L | 1 |
Clérin, E | 1 |
Blond, F | 1 |
Millet-Puel, G | 1 |
Mohand-Saïd, S | 1 |
Goureau, O | 1 |
Sahel, JA | 1 |
Nandrot, EF | 1 |
Léveillard, T | 1 |
Zhang, L | 1 |
Si, T | 1 |
Fischer, AJ | 1 |
Letson, A | 1 |
Yuan, S | 1 |
Roberts, CJ | 1 |
Xu, RX | 1 |
Lin, TC | 1 |
Hung, KH | 1 |
Peng, CH | 1 |
Liu, JH | 1 |
Woung, LC | 1 |
Tsai, CY | 1 |
Chen, SJ | 1 |
Chen, YT | 1 |
Hsu, CC | 1 |
Elsaid, N | 1 |
Jackson, TL | 1 |
Elsaid, Z | 1 |
Alqathama, A | 1 |
Somavarapu, S | 1 |
Kim, H | 1 |
Csaky, KG | 1 |
Kenney, MC | 1 |
Chwa, M | 1 |
Atilano, SR | 1 |
Pavlis, JM | 1 |
Falatoonzadeh, P | 1 |
Ramirez, C | 1 |
Malik, D | 1 |
Hsu, T | 1 |
Woo, G | 1 |
Soe, K | 1 |
Nesburn, AB | 1 |
Boyer, DS | 1 |
Kuppermann, BD | 1 |
Jazwinski, SM | 1 |
Miceli, MV | 1 |
Wallace, DC | 1 |
Udar, N | 1 |
Soboleva, G | 1 |
Geis, B | 1 |
Schrewe, H | 1 |
Weber, BH | 1 |
1 review available for lactic acid and Age-Related Macular Degeneration
Article | Year |
---|---|
Nanotechnology-based drug delivery treatments and specific targeting therapy for age-related macular degeneration.
Topics: Antibodies; Complement System Proteins; DNA-(Apurinic or Apyrimidinic Site) Lyase; Drug Delivery Sys | 2015 |
7 other studies available for lactic acid and Age-Related Macular Degeneration
Article | Year |
---|---|
Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics.
Topics: Angiogenesis Inhibitors; Biomarkers; Choroidal Neovascularization; Disease Management; Humans; Lacti | 2020 |
A Splice Variant in
Topics: Alternative Splicing; Biological Transport, Active; Epithelial Cells; Humans; Induced Pluripotent St | 2021 |
Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies.
Topics: Animals; Chickens; Delayed-Action Preparations; Drug Carriers; Intravitreal Injections; Lactic Acid; | 2015 |
PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Topics: Acetylcysteine; Cell Line; Cell Movement; Cell Survival; Chitosan; Drug Delivery Systems; Human Umbi | 2016 |
Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.
Topics: Animals; Choroidal Neovascularization; Fluorescein Angiography; Humans; Integrins; Lactic Acid; Macu | 2010 |
Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration.
Topics: Adenosine Triphosphate; Cells, Cultured; Complement C3; Complement Factor H; DNA, Mitochondrial; Epi | 2013 |
Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
Topics: Animals; Blotting, Western; Cell Line; Electrophoresis, Gel, Two-Dimensional; Extracellular Matrix; | 2003 |